These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report. Curtit E; Thiery-Vuillemin A; Nguyen T; Heyd B; Pivot X; Di Martino V; Borg C J Clin Oncol; 2011 Apr; 29(12):e330-2. PubMed ID: 21263091 [No Abstract] [Full Text] [Related]
3. Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus. Peng B; Liang L; He Q; Zhou F; Luo S Hepatogastroenterology; 2006; 53(69):415-9. PubMed ID: 16795984 [TBL] [Abstract][Full Text] [Related]
4. AFP measurement in monitoring treatment response of advanced hepatocellular carcinoma to sorafenib: case report and review of the literature. Gamstätter T; Weinmann A; Schadmand-Fischer S; Spies PR; Niederle IM; Schuchmann M; Galle PR; Wörns MA Onkologie; 2011; 34(10):538-42. PubMed ID: 21985853 [TBL] [Abstract][Full Text] [Related]
5. Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation. Kim R; El-Gazzaz G; Tan A; Elson P; Byrne M; Chang YD; Aucejo F Oncology; 2010; 79(1-2):62-6. PubMed ID: 21071991 [TBL] [Abstract][Full Text] [Related]
6. Complete pathological response induced by sorafenib for advanced hepatocellular carcinoma with multiple lung metastases and venous tumor thrombosis allowing for curative resection. Kitajima T; Hatano E; Mitsunori Y; Taura K; Fujimoto Y; Mizumoto M; Okajima H; Kaido T; Minamiguchi S; Uemoto S Clin J Gastroenterol; 2015 Oct; 8(5):300-5. PubMed ID: 26249525 [TBL] [Abstract][Full Text] [Related]
7. Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma. Chen XP; Qiu FZ; Wu ZD; Zhang ZW; Huang ZY; Chen YF; Zhang BX; He SQ; Zhang WG Ann Surg Oncol; 2006 Jul; 13(7):940-6. PubMed ID: 16788755 [TBL] [Abstract][Full Text] [Related]
8. Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan. Kudo M; Ueshima K Oncology; 2010 Jul; 78 Suppl 1():154-66. PubMed ID: 20616599 [TBL] [Abstract][Full Text] [Related]
9. Resection of hepatocellular carcinoma with tumor thrombus of the portal vein after neoadjuvant regional chemotherapy. Kamiyama H; Toyama N; Mori Y; Miyazaki K; Nagano M; Yamada S; Suminaga Y; Konishi F J Hepatobiliary Pancreat Surg; 2002; 9(6):759-63. PubMed ID: 12658413 [TBL] [Abstract][Full Text] [Related]
10. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch. Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255 [TBL] [Abstract][Full Text] [Related]
11. Regression of hepatocellular carcinoma with right atrial extension after sorafenib and transarterial chemoembolization. Subramanian M; Singal AG; Yopp AC Clin Gastroenterol Hepatol; 2012 Oct; 10(10):e83-4. PubMed ID: 22813441 [No Abstract] [Full Text] [Related]
12. 'I am not going to live to regret that, am I?' A pseudo-hepatocellular carcinoma case. Abbass K; Markert RJ; Kaplon MK Liver Int; 2011 Oct; 31(9):1418. PubMed ID: 21752176 [No Abstract] [Full Text] [Related]
13. Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma. Schmid I; Häberle B; Albert MH; Corbacioglu S; Fröhlich B; Graf N; Kammer B; Kontny U; Leuschner I; Scheel-Walter HG; Scheurlen W; Werner S; Wiesel T; von Schweinitz D Pediatr Blood Cancer; 2012 Apr; 58(4):539-44. PubMed ID: 21922643 [TBL] [Abstract][Full Text] [Related]
14. Contralateral glissonian pedicle occlusion in a case of portal vein tumor thrombosis. Fukushima D; Sato K; Sekiguchi S; Kawagishi N; Akamatsu Y; Ogawa N; Takada I; Miyagi S; Kobayashi Y; Fujimori K; Satomi S Hepatogastroenterology; 2012; 59(113):249-51. PubMed ID: 21940366 [TBL] [Abstract][Full Text] [Related]
15. [Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery]. Zhou J; Fan J; Tang ZY; Wu ZQ; Zhou XD; Ma ZC; Tan CJ; Shi YH; Yu Y; Qiu SJ Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):3005-8. PubMed ID: 17288818 [TBL] [Abstract][Full Text] [Related]
16. Clinical management and case reports for the treatment of hepatocellular carcinoma with sorafenib. Frenette CT; Frederick RT; Gish RG J Clin Gastroenterol; 2011 Sep; 45(8):733-7. PubMed ID: 20930642 [TBL] [Abstract][Full Text] [Related]
17. [Hepatic resection with removal of tumor thrombi for hepatocellular carcinoma with tumor thrombi in portal vein and curative analysis]. Fan J; Wu Z; Tang Z; Yu Y; Zhou J; Qiu S; Zhang B Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):8-11. PubMed ID: 11829766 [TBL] [Abstract][Full Text] [Related]